ES530669A0 - Un procedimiento para la preparacion de nuevos derivados de fosfolipidos - Google Patents
Un procedimiento para la preparacion de nuevos derivados de fosfolipidosInfo
- Publication number
- ES530669A0 ES530669A0 ES530669A ES530669A ES530669A0 ES 530669 A0 ES530669 A0 ES 530669A0 ES 530669 A ES530669 A ES 530669A ES 530669 A ES530669 A ES 530669A ES 530669 A0 ES530669 A0 ES 530669A0
- Authority
- ES
- Spain
- Prior art keywords
- phosfolipids
- procedure
- preparation
- new derivatives
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8222020 | 1982-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES530669A0 true ES530669A0 (es) | 1985-05-01 |
ES8602027A1 ES8602027A1 (es) | 1985-05-01 |
Family
ID=10532013
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES524610A Granted ES524610A0 (es) | 1982-07-30 | 1983-07-29 | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. |
ES530669A Expired ES8602027A1 (es) | 1982-07-30 | 1984-03-15 | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos |
ES530668A Expired ES8604243A1 (es) | 1982-07-30 | 1984-03-15 | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES524610A Granted ES524610A0 (es) | 1982-07-30 | 1983-07-29 | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES530668A Expired ES8604243A1 (es) | 1982-07-30 | 1984-03-15 | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos |
Country Status (6)
Country | Link |
---|---|
US (1) | US4585762A (es) |
EP (1) | EP0100499A3 (es) |
JP (1) | JPS5942394A (es) |
KR (1) | KR840005464A (es) |
DK (1) | DK347383A (es) |
ES (3) | ES524610A0 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3239817A1 (de) * | 1982-07-06 | 1984-01-12 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neue glycerinderivate zur synthese von phospholipiden |
JPS6122096A (ja) * | 1984-07-09 | 1986-01-30 | Kao Corp | 糖リン酸エステルおよびその製造方法 |
IT1244546B (it) * | 1991-02-01 | 1994-07-15 | Mediolanum Farmaceutici Spa | Analoghi del fosfatidilinositolo inibitori della fosfolipasi c fosfatidilinositolo-specifica |
JP2553171Y2 (ja) * | 1991-05-31 | 1997-11-05 | 東陶機器株式会社 | 便器装置 |
SE9102068L (sv) * | 1991-07-03 | 1993-01-04 | Perstorp Ab | Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav |
IT1255476B (it) * | 1992-07-30 | 1995-11-02 | Glicerofosfoderivati farmacologicamente attivi | |
DE4234130A1 (de) * | 1992-10-09 | 1994-04-14 | Max Planck Gesellschaft | Phospholipase A¶2¶ inhibierende Phosphatidylcholinverbindungen |
US5354853A (en) * | 1993-03-12 | 1994-10-11 | Genzyme Corporation | Phospholipid-saccharide conjugates |
US6551623B1 (en) | 1993-09-09 | 2003-04-22 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
EP0717631B1 (en) | 1993-09-09 | 2003-07-09 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
AU711294B2 (en) | 1995-03-16 | 1999-10-07 | Erin Mills Biotech Inc. | Immunomodulating compositions from bile for the treatment of immune system disorders |
US20040101569A1 (en) * | 1996-05-16 | 2004-05-27 | Lorus Therapeutics Inc. | Immunomodulating compositions from bile |
ATE308548T1 (de) * | 2000-11-07 | 2005-11-15 | I R B Istituto Di Ricerche Bio | Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren |
WO2004022569A1 (en) * | 2002-09-03 | 2004-03-18 | Georgetown University | Akt inhibitors, pharmaceutical compositions, and uses thereof |
US20110218176A1 (en) * | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2287901A1 (fr) * | 1974-10-14 | 1976-05-14 | Pasteur Institut | Medicament immunostimulant contenant un derive d'ose ou de polyose phosphoryle |
DE2659048A1 (de) * | 1976-12-27 | 1978-07-06 | Nattermann A & Cie | Neue inositphosphatid-derivate und verfahren zur herstellung dieser verbindungen |
-
1983
- 1983-07-13 US US06/513,451 patent/US4585762A/en not_active Expired - Fee Related
- 1983-07-23 KR KR1019830003406A patent/KR840005464A/ko not_active Application Discontinuation
- 1983-07-23 EP EP83107236A patent/EP0100499A3/en not_active Withdrawn
- 1983-07-28 DK DK347383A patent/DK347383A/da not_active Application Discontinuation
- 1983-07-29 JP JP58139709A patent/JPS5942394A/ja active Pending
- 1983-07-29 ES ES524610A patent/ES524610A0/es active Granted
-
1984
- 1984-03-15 ES ES530669A patent/ES8602027A1/es not_active Expired
- 1984-03-15 ES ES530668A patent/ES8604243A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0100499A3 (en) | 1985-06-12 |
JPS5942394A (ja) | 1984-03-08 |
EP0100499A2 (en) | 1984-02-15 |
ES8501410A1 (es) | 1984-12-01 |
DK347383A (da) | 1984-01-31 |
KR840005464A (ko) | 1984-11-12 |
ES8602027A1 (es) | 1985-05-01 |
ES530668A0 (es) | 1985-07-01 |
ES8604243A1 (es) | 1985-07-01 |
DK347383D0 (da) | 1983-07-28 |
ES524610A0 (es) | 1984-12-01 |
US4585762A (en) | 1986-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES540812A0 (es) | Un procedimiento para la preparacion de nuevos derivados delaminometil-oxooxazolidinil-benceno | |
ES524823A0 (es) | Un procedimiento para la preparacion de nuevas fenetanolaminas | |
ES554935A0 (es) | Un procedimiento para la preparacion de pirazolo- y piridazo-pirazolinas, -piridazinas y -diacepinas | |
ES502906A0 (es) | Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina | |
ES530714A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo | |
ES526295A0 (es) | Un procedimiento para la preparacion de derivados de 1-normon-2-ilo | |
ES531659A0 (es) | Un procedimiento para la preparacion de nuevos derivados de arilamida | |
ES521635A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos. | |
ES541229A0 (es) | Un procedimiento para la preparacion de nuevos derivados delcromano | |
ES535980A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina | |
ES524447A0 (es) | Un procedimiento para la preparacion de nuevos derivados arilfenolicos. | |
ES524922A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno | |
ES544140A0 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
ES524399A0 (es) | Un procedimiento para la preparacion de derivados de milbenicina d | |
ES530668A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos | |
ES524317A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tienopirimidina. | |
ES492230A0 (es) | Un procedimiento para la preparacion de nuevos derivados de carbostirilo | |
ES522389A0 (es) | Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos. | |
ES540347A0 (es) | Un procedimiento para la preparacion de derivados de piperi-dina | |
ES527804A0 (es) | Un procedimiento para la preparacion de derivados de oxacefalosporina | |
ES529879A0 (es) | Un procedimiento para la preparacion de nuevos benzonitrilos | |
ES545776A0 (es) | Un procedimiento para la preparacion de nuevos derivados de feniletanamina | |
ES527232A0 (es) | Un procedimiento para la preparacion de nuevos derivados de triazol | |
ES526294A0 (es) | Un procedimiento para la preparacion de derivados pentaciclicos | |
ES535101A0 (es) | Un procedimiento para la preparacion de nuevos derivados de pirrol-2-acetilaminoacido |